| 11912998 |
Method of treating aging-associated cognitive impairment by reducing CCR3 |
Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda |
2024-02-27 |
| 11236340 |
Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3) |
Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda |
2022-02-01 |
| 10647761 |
Anti-alpha-synuclein antibodies and methods of use |
Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber |
2020-05-12 |
| 10626399 |
Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
Anton Wyss-Coray, Thomas A. Rando, Kaspar Rufibach, Saul A. Villeda |
2020-04-21 |
| 10316082 |
Anti-alpha-synuclein antibodies and methods of use |
Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber |
2019-06-11 |
| 9890209 |
Anti-alpha-synuclein antibodies and methods of use |
Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber |
2018-02-13 |
| 9670274 |
Anti-alpha-synuclein antibodies and methods of use |
Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber |
2017-06-06 |
| 9493553 |
Anti-alpha-synuclein antibodies and methods of use |
Klaus Kaluza, Olaf Mundigl, Thomas Kremer, Sylwia Huber |
2016-11-15 |
